Viewing Study NCT01140061


Ignite Creation Date: 2025-12-24 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 10:20 AM
Study NCT ID: NCT01140061
Status: COMPLETED
Last Update Posted: 2019-02-08
First Post: 2010-06-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 0873-020
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators